DMAC
DiaMedica Therapeutics Inc
7.60$
-2.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +66.6% | -46.6% | +82.1% | +275.0% | +40.0% | +0.0% | +14.3% | +4.2% | +20.0% | +30.0% | -2,405.1% | |
| – | -63.4% | +109.8% | +55.3% | +51.6% | +87.7% | +58.3% | -15.5% | -3.6% | +12.1% | +23.9% | +84.5% | |
| – | -59.6% | -53.7% | +244.2% | +64.8% | +76.6% | +58.3% | -3.6% | -12.5% | – | – | – | |
| – | -112.1% | – | – | – | – | +208.8% | -138.6% | – | -84.1% | +1,525.8% | -55.4% | |
| – | -82.8% | +27.9% | +219.2% | +127.3% | -96.0% | +2,250.0% | -53.2% | +268.2% | -70.4% | +4.2% | +60.0% | |
| – | -82.8% | +27.9% | +219.2% | +127.3% | +7,716.0% | +312.8% | +27.3% | – | -258.6% | – | -125.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.4% | +205.2% | -22.9% | +499.5% | -99.6% | +38,366.9% | – | – | – | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +20.0% | +0.0% | +0.0% | +50.0% | +11.1% | |
| – | -18.6% | +236.1% | -22.9% | +499.5% | -99.7% | +41,107.1% | +4.3% | -100.0% | – | -67.4% | +265.8% | |
| – | – | – | -124.4% | – | -183.6% | – | -176.6% | – | -981.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.